These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 8257827)

  • 21. Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation.
    Martí F; Pardo N; Peiró M; Bertran E; Amill B; García J; Cubells J; Rueda F
    Exp Hematol; 1995 Dec; 23(14):1445-52. PubMed ID: 8542930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zinc improves the development of human CD34+ cell progenitors towards Natural Killer cells and induces the expression of GATA-3 transcription factor.
    Muzzioli M; Stecconi R; Donnini A; Re F; Provinciali M
    Int J Biochem Cell Biol; 2007; 39(5):955-65. PubMed ID: 17306601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood.
    Mills KC; Gross TG; Varney ML; Heimann DG; Reed EC; Kessinger A; Talmadge JE
    Bone Marrow Transplant; 1996 Jul; 18(1):53-61. PubMed ID: 8831996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multifactorial analysis of umbilical cord blood, adult bone marrow and mobilized peripheral blood progenitors using the improved ML-IC assay.
    Theunissen K; Verfaillie CM
    Exp Hematol; 2005 Feb; 33(2):165-72. PubMed ID: 15676210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of natural killer cells from long-term cultures of mouse bone marrow.
    Vecchini F; Delfino D; Patrene KD; DeLeo A; Lu L; Herberman RB; Boggs SS
    Nat Immun; 1993; 12(1):1-16. PubMed ID: 8431659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD16+ CD56- NK cells in the peripheral blood of cord blood transplant recipients: a unique subset of NK cells possibly associated with graft-versus-leukemia effect.
    Lu X; Kondo Y; Takamatsu H; Ohata K; Yamazaki H; Takami A; Akatsuka Y; Nakao S
    Eur J Haematol; 2008 Jul; 81(1):18-25. PubMed ID: 18363874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural killer cell numbers and activity in mobilized peripheral blood stem cell grafts: conditions for in vitro expansion.
    Silva MR; Parreira A; Ascensão JL
    Exp Hematol; 1995 Dec; 23(14):1676-81. PubMed ID: 8542964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of NK cell activity against fresh human leukemia in culture with interleukin 2.
    Lotzová E; Savary CA; Herberman RB
    J Immunol; 1987 Apr; 138(8):2718-27. PubMed ID: 3494084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotypic and cytolytic activity of Macaca nemestrina natural killer cells isolated from blood and expanded in vitro.
    Shields LE; Sieverkropp AJ; Potter J; Andrews RG
    Am J Primatol; 2006 Aug; 68(8):753-64. PubMed ID: 16847969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiology of natural killer cells. In vivo regulation of progenitors by interleukin 3.
    Kalland T
    J Immunol; 1987 Dec; 139(11):3671-5. PubMed ID: 3500227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotypic and functional characterization of peripheral blood and bone marrow natural killer cells prior to autologous transplantation.
    Arbour S; Toupin S; Bélanger R; Gyger M; Hallé JP; Perreault C; Roy DC
    Bone Marrow Transplant; 1996 Mar; 17(3):315-22. PubMed ID: 8704680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hematopoietic origin of human natural killer (NK) cells: generation from immature progenitors.
    Silva MR; Kessler S; Ascensao JL
    Pathobiology; 1993; 61(5-6):247-55. PubMed ID: 7507682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human thymic stroma supports human natural killer (NK) cell development from immature progenitors.
    Vaz F; Srour EF; Almeida-Porada G; Ascensao JL
    Cell Immunol; 1998 Jun; 186(2):133-9. PubMed ID: 9665755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural killer (NK) cell generation in bone marrow cultures: role of IL-1 alpha.
    Ayroldi E; Cannarile L; Riccardi C
    Immunopharmacol Immunotoxicol; 1991; 13(4):589-606. PubMed ID: 1774437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A clinically suitable ex vivo expansion culture system for LTC-IC and CFC using stroma-conditioned medium.
    Bhatia R; McGlave PB; Miller JS; Wissink S; Lin WN; Verfaillie CM
    Exp Hematol; 1997 Aug; 25(9):980-91. PubMed ID: 9257812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural killer cells generated from bone marrow culture.
    Koo GC; Peppard JR; Mark WH
    J Immunol; 1984 May; 132(5):2300-4. PubMed ID: 6201540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and validation of a clinically applicable culture procedure for the generation of interleukin-2 activated natural killer cells in human bone marrow autografts.
    Klingemann HG; Deal H; Reid D; Eaves CJ
    Exp Hematol; 1993 Aug; 21(9):1263-70. PubMed ID: 8330650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between IL-3 receptor expression and growth potential of human CD34+ hematopoietic cells from different tissues.
    Huang S; Chen Z; Yu JF; Young D; Bashey A; Ho AD; Law P
    Stem Cells; 1999; 17(5):265-72. PubMed ID: 10527461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production and differentiation of NK linkage cells in bone marrow.
    Pollack SB
    Nat Immun; 1993; 12(4-5):177-93. PubMed ID: 8257825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia.
    Robertson MJ; Cochran KJ; Cameron C; Le JM; Tantravahi R; Ritz J
    Exp Hematol; 1996 Feb; 24(3):406-15. PubMed ID: 8599969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.